CNW/ - Pharmascience Canada is proud to announce the launch of  Pr  pms-RUPATADINE (rupatadine), a treatment that helps relieve nasal and non-nasal ...

KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...

More than 100 million Americans experience allergies to everyday exposures like pollen, mold and pet fur, according to data ...

CFO Vanessa Kanu reported Q4 adjusted EBITDA of $195 million, representing a 9% increase year-over-year. She attributed the 27% increase in adjusted diluted EPS to strong margins and a lower tax rate ...

Driving under the influence of certain medications might not be the best idea. But before making any decisions, let's get informed! Swipe through and find out more!

The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...

A woman who is living with over 40 allergies, including water, has shared how she has to use a colour-coded spread sheet to ...

Goodman also blamed "institutional inertia" and "circular reasoning" – that agencies had always experimented on animals – for not innovating outside animals, while Locke said feds were "passive and ...

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...

Cal Yee Farms is recalling several of its popular chocolate treats due to a labeling mistake that could be deadly for people ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...